Smith & Nephew (SNNUF) Non-Current Assets (2009 - 2025)
Smith & Nephew (SNNUF) reported Non-Current Assets of $6.4 billion for Q4 2025, up 7.1% on a YoY basis from $5.9 billion in Q4 2024, and up 7.1% quarter-over-quarter from $5.9 billion in Q4 2024.
Smith & Nephew (SNNUF) Non-Current Assets (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Non-Current Assets for 17 years, with the latest figure at $6.4 billion in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets rose 7.1% year-over-year to $6.4 billion; the trailing twelve-month figure through Dec 2025 stood at $6.4 billion (up 7.1% YoY), and the FY2025 full-year result was $6.4 billion, up 7.1% from the prior year.
- Non-Current Assets for Q4 2025 stood at $6.4 billion, up from $5.9 billion in the prior quarter.
- The five-year high for Non-Current Assets was $6.5 billion in Q4 2021, with the low at $5.9 billion in Q4 2024.
- Historically, Non-Current Assets has averaged $6.2 billion across 5 years, with a median of $6.1 billion in 2022.
- Annual changes were most pronounced in 2022 — Non-Current Assets dropped 5.94% — and 2025, when it advanced 7.1%.
- Smith & Nephew's Non-Current Assets stood at $6.5 billion in 2021, then fell by 5.94% to $6.1 billion in 2022, then fell by 2.5% to $6.0 billion in 2023, then dropped by 0.4% to $5.9 billion in 2024, then grew by 7.1% to $6.4 billion in 2025.
- The last three Non-Current Assets figures came in at $6.4 billion (Q4 2025), $5.9 billion (Q4 2024), and $6.0 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Smith & Nephew | - | - | - | 6.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.35 Bn |
| Dec 31, 2024 | 5.93 Bn |
| Dec 31, 2023 | 5.96 Bn |
| Dec 31, 2022 | 6.11 Bn |
| Dec 31, 2021 | 6.50 Bn |
| Dec 31, 2020 | 6.35 Bn |
| Dec 31, 2019 | 6.08 Bn |
| Dec 31, 2018 | 4.98 Bn |
| Dec 31, 2017 | 5.14 Bn |
| Dec 31, 2016 | 4.82 Bn |
| Dec 31, 2015 | 4.69 Bn |
| Jun 30, 2015 | 4.78 Bn |
| Dec 31, 2014 | 4.87 Bn |
| Jun 28, 2014 | 5.21 Bn |
| Mar 31, 2014 | 3.55 Bn |
| Dec 31, 2013 | 3.56 Bn |
| Sep 28, 2013 | 3.40 Bn |
| Mar 31, 2013 | 3.40 Bn |
| Dec 31, 2012 | 3.50 Bn |
| Sep 29, 2012 | 2.71 Bn |